Get my own profile
Public access
View all23 articles
2 articles
available
not available
Based on funding mandates
Co-authors
- Veronique PreatProfesseur, Université catholique de LouvainVerified email at uclouvain.be
- Kiran Kumar ChereddyUniversite catholique de Louvain, Lonza BiologicsVerified email at lonza.com
- Héloïse RagelleMassachusetts Institute of TechnologyVerified email at mit.edu
- Anne des RieuxUniversité catholique de LouvainVerified email at uclouvain.be
- Gregor SersaHead of Department, Department of Experimental Oncology, Institute of Oncology LjubljanaVerified email at onko-i.si
- Pierre SonveauxUniversity of Louvain (UCL) Medical SchoolVerified email at uclouvain.be
- Helena F. FlorindoProfessor, University of LisbonVerified email at ff.ul.pt
- Maja CemazarDepartment of Experimental Oncology, Institute of Oncology LjubljanaVerified email at onko-i.si
- Paolo Ettore PorporatoUniversity of TurinVerified email at unito.it
- Julie VanackerUniversité catholique de LouvainVerified email at uclouvain.be
- Olivier FeronUCLouvainVerified email at uclouvain.be
- Van den Eynde BenoitDirector, Brussels Branch of the Ludwig Institute for Cancer Research; Professor of Immunology, Univ. catholique de Louvain, de Verified email at bru.licr.org
- Camilla FogedProfessor of Vaccine Design and Delivery, University of CopenhagenVerified email at sund.ku.dk
- Pascal Kienlen-CampardUniversité catholique de LouvainVerified email at uclouvain.be
- Christine Dupont-GillainProfessor and researcher, physical chemistry of biointerfacesVerified email at uclouvain.be
- Carina PeresPostdoctoral research fellow at CICS-UBIVerified email at fcsaude.ubi.pt
- Takis AthanasopoulosDirector, Head of Transgene Delivery, Cell & Gene Therapy Discovery Research (CGTDR), PlatformVerified email at gsk.com
- Julien VerraxUniversité catholique de Louvain